Literature DB >> 18553946

Antitumoral effect of phenazine N5,N10-dioxide derivatives on Caco-2 cells.

Olga Gisela Pachón1, Amaia Azqueta, Maria Laura Lavaggi, Adela López de Cerain, Edmond Creppy, Andrew Collins, Hugo Cerecetto, Mercedes González, Josep Joan Centelles, Marta Cascante.   

Abstract

We studied the in vitro antitumoral effect of a series of phenazine di- N-oxide derivatives, named 2-chloroacetylamino-7(8)-nitrophenazine N(5), N(10)-dioxide (1), 2-amino-7(8)-(1,3-dioxol-2-yl)phenazine N(5), N(10)-dioxide (2), 2-chloroacetylamino-7(8)-(1,3-dioxol-2-yl)phenazine N(5), N(10)-dioxide (3), and 2-amino-7(8)-methoxyphenazine N(5), N(10)-dioxide (4), on Caco-2 cells. These phenazine N(5), N(10)-dioxide derivatives belong to our in-house chemical library. The products were selected according to their stereoelectronic characteristics and taking into account their differential cytotoxicity against V79 cells. Human colorectal adenocarcinoma cell line Caco-2 was used to study the cell growth inhibition capacity of these compounds, their capacity of altering the cell cycle and possible induction of apoptosis, DNA fragmentation, and genotoxic damage. The IC 50 after 24 h of incubation was lower for 1, 2, and 3 (4.8, 46.8, and 8.2 microM, respectively) than for 4 (474.7 microM). Compound 1 induced arrest in the G2/M phase at 24 and 48 h of treatment and apoptosis at the highest doses at 24 h of treatment. These facts were corroborated with caspase 3, caspase 9, and cytochrome c activation and DNA fragmentation at 24 h of treatment. The derivatives studied induced neither significant single strand breaks nor oxidative damage at the different studied times. We concluded that among the series of N(5), N(10)-dioxide phenazine derivatives analyzed, 1, which contains a nitro moiety and a chloroacetamide group, is the most promising as an antitumoral compound.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18553946     DOI: 10.1021/tx800032k

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  4 in total

1.  Novel Phenazine 5,10-Dioxides Release OH in Simulated Hypoxia and Induce Reduction of Tumour Volume In Vivo.

Authors:  María L Lavaggi; Mauricio Cabrera; Cristina Pintos; Carolina Arredondo; Gisela Pachón; Jorge Rodríguez; Stella Raymondo; José Pedro Pacheco; Marta Cascante; Claudio Olea-Azar; Adela López de Ceráin; Antonio Monge; Hugo Cerecetto; Mercedes González
Journal:  ISRN Pharmacol       Date:  2011-06-22

2.  Unveiling the Metabolic Changes on Muscle Cell Metabolism Underlying p-Phenylenediamine Toxicity.

Authors:  Igor Marín de Mas; Silvia Marín; Gisela Pachón; Juan C Rodríguez-Prados; Pedro Vizán; Josep J Centelles; Romà Tauler; Amaya Azqueta; Vitaly Selivanov; Adela López de Ceraín; Marta Cascante
Journal:  Front Mol Biosci       Date:  2017-03-06

3.  Development and Evaluation of 2-Amino-7-Fluorophenazine 5,10-Dioxide Polymeric Micelles as Antitumoral Agents for 4T1 Breast Cancer.

Authors:  Nicole Lecot; Belén Dávila; Carina Sánchez; Marcelo Fernández; Mercedes González; Pablo Cabral; Hugo Cerecetto; Romina Glisoni
Journal:  Polymers (Basel)       Date:  2021-12-25       Impact factor: 4.329

Review 4.  Advances in Phenazines over the Past Decade: Review of Their Pharmacological Activities, Mechanisms of Action, Biosynthetic Pathways and Synthetic Strategies.

Authors:  Junjie Yan; Weiwei Liu; Jiatong Cai; Yiming Wang; Dahong Li; Huiming Hua; Hao Cao
Journal:  Mar Drugs       Date:  2021-10-27       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.